Search Results - Mike R. Russell

  • Showing 1 - 9 results of 9
Refine Results
  1. 1
    Interleukin-1β Promotes Skeletal Colonization and Progression of Metastatic Prostate Cancer Cells with Neuroendocrine Features

    Interleukin-1β Promotes Skeletal Colonization and Progression of Metastatic Prostate Cancer Cells with Neuroendocrine Features by Qingxin Liu, Mike R. Russell, Kristina Shahriari, Danielle L. Jernigan, Mercedes Lioni, Fernando U. Garcia, Alessandro Fatatis

    Published 2013
    Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    The functional variant rs34330 of <i>CDKN1B</i> is associated with risk of neuroblastoma

    The functional variant rs34330 of <i>CDKN1B</i> is associated with risk of neuroblastoma by Mario Capasso, Lee McDaniel, Flora Cimmino, Andrea Cirino, Daniela Formicola, Mike R. Russell, Pichai Raman, Kristina A. Cole, Sharon J. Diskin

    Published 2017
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Combination Therapy Targeting the Chk1 and Wee1 Kinases Shows Therapeutic Efficacy in Neuroblastoma

    Combination Therapy Targeting the Chk1 and Wee1 Kinases Shows Therapeutic Efficacy in Neuroblastoma by Mike R. Russell, Kirill Levin, JulieAnn Rader, Lili T. Belcastro, Yimei Li, Daniel Martínez, Bruce Pawel, Stuart D. Shumway, John M. Maris, Kristina A. Cole

    Published 2012
    Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    Rare Variants in TP53 and Susceptibility to Neuroblastoma

    Rare Variants in TP53 and Susceptibility to Neuroblastoma by Sharon J. Diskin, Mario Capasso, Maura Diamond, Derek A. Oldridge, Karina L. Conkrite, Kristopher R. Bosse, Mike R. Russell, Achille Iolascon, Hákon Hákonarson, Marcella Devoto, John M. Maris

    Published 2014
    Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Knockdown of PTHR1 in osteosarcoma cells decreases invasion and growth and increases tumor differentiation in vivo

    Knockdown of PTHR1 in osteosarcoma cells decreases invasion and growth and increases tumor differentiation in vivo by P.W.M. Ho, Ankita Goradia, Mike R. Russell, Alistair M. Chalk, Kristi Milley, Emma Baker, Janine A. Danks, Joanne Slavin, Mannu Walia, Blessing Crimeen‐Irwin, Ross A. Dickins, T. John Martin, Carl R. Walkley

    Published 2014
    Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    CASC15-S Is a Tumor Suppressor lncRNA at the 6p22 Neuroblastoma Susceptibility Locus

    CASC15-S Is a Tumor Suppressor lncRNA at the 6p22 Neuroblastoma Susceptibility Locus by Mike R. Russell, Annalise Penikis, Derek A. Oldridge, Juan R. Alvarez‐Dominguez, Lee McDaniel, Maura Diamond, Olivia Padovan, Pichai Raman, Yimei Li, Jun S. Wei, Shile Zhang, Janahan Gnanchandran, Robert C. Seeger, Shahab Asgharzadeh, Javed Khan, Sharon J. Diskin, John M. Maris, Kristina A. Cole

    Published 2015
    Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Dual CDK4/CDK6 Inhibition Induces Cell-Cycle Arrest and Senescence in Neuroblastoma

    Dual CDK4/CDK6 Inhibition Induces Cell-Cycle Arrest and Senescence in Neuroblastoma by JulieAnn Rader, Mike R. Russell, Lori S. Hart, Michael S. Nakazawa, Lili T. Belcastro, Daniel Martínez, Yimei Li, Erica L. Carpenter, Edward F. Attiyeh, Sharon J. Diskin, Sunkyu Kim, Sudha Parasuraman, Giordano Caponigro, Robert W. Schnepp, Andrew Wood, Bruce Pawel, Kristina A. Cole, John M. Maris

    Published 2013
    Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Preclinical Therapeutic Synergy of MEK1/2 and CDK4/6 Inhibition in Neuroblastoma

    Preclinical Therapeutic Synergy of MEK1/2 and CDK4/6 Inhibition in Neuroblastoma by Lori S. Hart, JulieAnn Rader, Pichai Raman, Vandana Batra, Mike R. Russell, Matthew Tsang, Maria Gagliardi, Lucy Chen, Daniel Martínez, Yimei Li, Andrew Wood, Sunkyu Kim, Sudha Parasuraman, Scott Delach, Kristina A. Cole, Shiva Krupa, Markus Boehm, Malte Peters, Giordano Caponigro, John M. Maris

    Published 2016
    Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    RNAi screen of the protein kinome identifies checkpoint kinase 1 (CHK1) as a therapeutic target in neuroblastoma

    RNAi screen of the protein kinome identifies checkpoint kinase 1 (CHK1) as a therapeutic target in neuroblastoma by Kristina A. Cole, Jonathan H. Huggins, Michael P. LaQuaglia, Chase E. Hulderman, Mike R. Russell, Kristopher R. Bosse, Sharon J. Diskin, Edward F. Attiyeh, Rachel Sennett, Geoffrey T. Norris, Marci Laudenslager, Andrew Wood, Patrick A. Mayes, Jayanti Jagannathan, Cynthia Winter, Yaël P. Mossé, John M. Maris

    Published 2011
    Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: